Opportunities for selective reporting of harms in randomized clinical trials: Selection criteria for non-systematic adverse events
Abstract Background Adverse events (AEs) in clinical trials may be reported in multiple sources. Different methods for reporting adverse events across trials or across sources for a single trial may produce inconsistent information about the adverse events associated with interventions. Methods We c...
Main Authors: | Evan Mayo-Wilson, Nicole Fusco, Hwanhee Hong, Tianjing Li, Joseph K. Canner, Kay Dickersin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-09-01
|
Series: | Trials |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13063-019-3581-3 |
Similar Items
-
Caveat emptor: the combined effects of multiplicity and selective reporting
by: Tianjing Li, et al.
Published: (2018-09-01) -
Reporting of harms in oncological clinical study reports submitted to the European Medicines Agency compared to trial registries and publications—a methodological review
by: Asger S. Paludan-Müller, et al.
Published: (2021-04-01) -
Adverse Events Reporting of Clinical Trials in Exercise Oncology Research (ADVANCE): Protocol for a Scoping Review
by: Hao Luo, et al.
Published: (2022-02-01) -
Three aspects of acupuncture-related adverse events: Issues around the reporting of acupuncture-related adverse events
by: Tae-Hun Kim, et al.
Published: (2023-09-01) -
Profile of rheumatology patients willing to report adverse drug reactions: bias from selective reporting
by: Protić D, et al.
Published: (2016-02-01)